S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
Log in

NASDAQ:EXPOExponent Stock Price, Forecast & News

$83.39
-0.67 (-0.80 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$83.38
Now: $83.39
$84.62
50-Day Range
$72.16
MA: $79.38
$84.06
52-Week Range
$58.03
Now: $83.39
$84.62
Volume152,283 shs
Average Volume285,186 shs
Market Capitalization$4.30 billion
P/E Ratio54.86
Dividend Yield0.90%
Beta0.27
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Read More
Exponent logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.69 out of 5 stars


Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryResearch & Consulting Services
Current SymbolNASDAQ:EXPO
CUSIP30214U10
Phone650-326-9400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$417.20 million
Cash Flow$1.70 per share
Book Value$6.76 per share

Profitability

Net Income$82.46 million

Miscellaneous

Employees1,201
Market Cap$4.30 billion
Next Earnings Date10/15/2020 (Estimated)
OptionableOptionable
$83.39
-0.67 (-0.80 %)
(As of 08/3/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Exponent (NASDAQ:EXPO) Frequently Asked Questions

How has Exponent's stock been impacted by COVID-19 (Coronavirus)?

Exponent's stock was trading at $75.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EXPO shares have increased by 9.7% and is now trading at $83.39.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Exponent?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Exponent
.

When is Exponent's next earnings date?

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, October 15th 2020.
View our earnings forecast for Exponent
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) announced its quarterly earnings results on Thursday, July, 30th. The business services provider reported $0.31 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.22 by $0.09. The business services provider had revenue of $87.86 million for the quarter, compared to analysts' expectations of $85.11 million. Exponent had a net margin of 19.87% and a return on equity of 23.87%.
View Exponent's earnings history
.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Monday, August 3rd. Shareholders of record on Friday, September 11th will be paid a dividend of $0.19 per share on Friday, September 25th. This represents a $0.76 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date of this dividend is Thursday, September 10th.
View Exponent's dividend history
.

When did Exponent's stock split? How did Exponent's stock split work?

Exponent shares split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were distributed to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

What price target have analysts set for EXPO?

5 analysts have issued 12-month price targets for Exponent's shares. Their forecasts range from $81.00 to $94.00. On average, they anticipate Exponent's stock price to reach $86.33 in the next twelve months. This suggests a possible upside of 3.5% from the stock's current price.
View analysts' price targets for Exponent
.

Has Exponent been receiving favorable news coverage?

News stories about EXPO stock have been trending negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Exponent earned a news sentiment score of -2.9 on InfoTrie's scale. They also gave news articles about the business services provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future.
View the latest news about Exponent
.

Are investors shorting Exponent?

Exponent saw a decline in short interest in July. As of July 15th, there was short interest totaling 872,200 shares, a decline of 10.7% from the June 30th total of 977,200 shares. Based on an average trading volume of 283,600 shares, the short-interest ratio is currently 3.1 days. Approximately 1.7% of the shares of the company are sold short.
View Exponent's Current Options Chain
.

Who are some of Exponent's key competitors?

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Energy Transfer LP Unit (ET), Pfizer (PFE), Abbott Laboratories (ABT), Ford Motor (F), AT&T (T), Adobe (ADBE), Intel (INTC), Micron Technology (MU) and UnitedHealth Group (UNH).

Who are Exponent's key executives?

Exponent's management team includes the following people:
  • Dr. Paul R. Johnston, Exec. Chairman (Age 65)
  • Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 50)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 53)
  • Dr. Harri K. Kytomaa, Group VP & Principal Engineer (Age 60)
  • Dr. Steven J. Murray, Group VP & Principal Engineer (Age 44)

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Who are Exponent's major shareholders?

Exponent's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.51%), Riverbridge Partners LLC (1.78%), Copeland Capital Management LLC (0.80%), Redwood Investments LLC (0.49%), Envestnet Asset Management Inc. (0.41%) and Raymond James & Associates (0.30%). Company insiders that own Exponent stock include Bradley A James, Carol Lindstrom, Harri Kytomaa, John Pye, Paul R Johnston and Richard L Schlenker Jr.
View institutional ownership trends for Exponent
.

Which institutional investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including Redwood Investments LLC, UBS Group AG, Brinker Capital Inc., SG Americas Securities LLC, Robeco Institutional Asset Management B.V., 6 Meridian, Bridge City Capital LLC, and Stone Ridge Asset Management LLC. Company insiders that have sold Exponent company stock in the last year include Bradley A James, Harri Kytomaa, John Pye, Paul R Johnston, and Richard L Schlenker Jr.
View insider buying and selling activity for Exponent
.

Which institutional investors are buying Exponent stock?

EXPO stock was purchased by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Raymond James & Associates, Copeland Capital Management LLC, Strs Ohio, Envestnet Asset Management Inc., First Trust Advisors LP, Sumitomo Mitsui Trust Holdings Inc., and Exchange Traded Concepts LLC.
View insider buying and selling activity for Exponent
.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $83.39.

How big of a company is Exponent?

Exponent has a market capitalization of $4.30 billion and generates $417.20 million in revenue each year. The business services provider earns $82.46 million in net income (profit) each year or $1.53 on an earnings per share basis. Exponent employs 1,201 workers across the globe.

What is Exponent's official website?

The official website for Exponent is www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]

This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.